Reprogramming Immunity to Rewrite the Story of Type 1 Diabetes

With $1 million in funding from Breakthrough T1D, Dr. Leonardo Ferreira and his collaborators will explore a new approach to treating type 1 diabetes. Dr. Ferreira brings to the field his expertise in engineering the immune system by creating chimeric antigen receptors, that help Tregs to find their targets.